Delivery Order SPE2DB20D2104-SPE2DB23FQ86D

Award Date 10/26/22
Potential Completion Date 10/27/22
Potential Value $8.2K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,131.96, is for the delivery of 4,559,590 units of the drug Uroxatral (Alfuzosin HCl) 10mg tablets. The award date is January 12, 2023, with a completion date of January 13, 2023. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen is...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Uroxatral 10 mg tablets. The $11,916.73 award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, which provides a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract has no set-aside...
This is a $43,711.31 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,562,473,580 units of the prescription drug UROXATRAL 10 mg tablets. The contract has an ultimate completion date of October 16, 2023. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This is a delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $15,152.40 firm-fixed-price contract is for the delivery of 4,564,829,060 units of the medication Uroxatral (alfuzosin hydrochloride) 10 mg tablets. The order has a completion date of June 7, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Uroxatral 10 mg tablets. The $9,582.62 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen's parent company, Cencora, Inc., and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,917.96, is for the supply of UROXATRAL 10 MG TABLET 100S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is February 16, 2024. The award is associated with a larger Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Uroxatral 10 mg tablets, a medication used to treat benign prostatic hyperplasia. The contract has a ceiling value of $27,272.45 and a period of performance through October 18, 2023. It is a firm-fixed-price contract and was not set aside for any specific business classification....
This federal contract award, valued at $70,867.67, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,562,252,774 units of the prescription medication Uroxatral 10 mg tablets. The award is a delivery order issued under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling...
This federal contract award, valued at $41,212.91, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The delivery order contract is for the procurement of Uroxatral 10 mg tablets, a medication used to treat benign prostatic hyperplasia. The contract has a period of performance through February 20, 2024 and is a firm fixed-price arrangement. Amerisourcebergen holds a significant Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,558,157,684 units of Uroxatral 10 mg Tablets in quantities of 100 per bottle. The award, valued at $72,282.72, has a firm fixed price and an ultimate completion date of August 22, 2022. The contract is not designated as a set-aside. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB23FQ86D
    Delivery Order

This federal contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,558,895 units of the prescription drug Uroxatral (alfuzosin hydrochloride) 10 mg tablets. The contract, valued at $8,161.42, is a firm-fixed-price delivery order with a completion date of October 27, 2022. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. The IDC serves as a primary vehicle for AmerisourceBergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not indicate any set-aside designations, suggesting it was awarded through full and open competition.

Generated 2/27/25, 10:24 AM